These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 19231606

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital.
    Lertcharernrit J, Sananpanichkul P, Suknikhom W, Bhamarapravatana K, Suwannarurk K, Leaungsomnapa Y.
    Asian Pac J Cancer Prev; 2016; 17(8):4163-7. PubMed ID: 27644678
    [Abstract] [Full Text] [Related]

  • 44. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
    Sawaya GF.
    Arch Intern Med; 2010 Jun 14; 170(11):985-6. PubMed ID: 20548012
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
    Syrjänen K.
    Eur J Gynaecol Oncol; 2008 Jun 14; 29(3):205-21. PubMed ID: 18592782
    [Abstract] [Full Text] [Related]

  • 47. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
    Jin XW, Xu H.
    Compr Ther; 2001 Jun 14; 27(3):202-8. PubMed ID: 11569320
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J, Morelos HPV Study Collaborators.
    Salud Publica Mex; 2002 Jun 14; 44(4):335-44. PubMed ID: 12216521
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Screening adolescents and young women.
    Boardman LA, Robison K.
    Obstet Gynecol Clin North Am; 2013 Jun 14; 40(2):257-68. PubMed ID: 23732030
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Anticipating the Impact of Human Papillomavirus Vaccination on US Cervical Cancer Prevention Strategies.
    Massad LS.
    J Low Genit Tract Dis; 2018 Apr 14; 22(2):123-125. PubMed ID: 29474243
    [Abstract] [Full Text] [Related]

  • 58. Value of conventional pap smear, liquid-based cytology, visual inspection and human papillomavirus testing as optional screening tools among latin american women <35 and > or =35 years of age: experience from the Latin American Screening Study.
    Syrjänen K, Derchain S, Roteli-Martins C, Longatto-Filho A, Hammes LS, Sarian L, Latin American Screening Study Group.
    Acta Cytol; 2008 Apr 14; 52(6):641-53. PubMed ID: 19068666
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.